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Abstract
The activation of soluble guanylate cyclase (sGC) by nitric oxide (NO) and other ligands has been extensively investigated for
many years. In the present study we considered the effect of molecular oxygen (O2) on sGC both as a direct ligand and its
affect on other ligands by measuring cyclic guanosine monophosphate (cGMP) production, as an index of activity, as well as
investigating smooth muscle relaxation under hypoxic conditions. Our isolated enzyme studies confirm the function of sGC
is impaired under hypoxic conditions and produces cGMP in the presence of O2, importantly in the absence of NO. We also
show that while O2 could partially affect the magnitude of sGC stimulation by NO when the latter was present in excess,
activation by the NO independent, haem-dependent sGC stimulator 3-(59-hydroxymethyl-29-furyl)-1-benzylindazole (YC-1)
was unaffected. Our in vitro investigation of smooth muscle relaxation confirmed that O2 alone in the form of a buffer bolus
(equilibrated at 95% O2/5% CO2) had the ability to dilate vessels under hypoxic conditions and that this was dependent
upon sGC and independent of eNOS. Our studies confirm that O2 can be a direct and important mediator of vasodilation
through an increase in cGMP production. In the wider context, these observations are key to understanding the relative
roles of O2 versus NO-induced sGC activation.
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Introduction
Soluble guanylate cyclase (sGC) is well known as the ‘‘receptor’’
for nitric oxide (NO). Binding of this gaseous diatomic molecule to
the haem moiety of the enzyme stimulates the conversion of
guanosine triphosphate (GTP) to cyclic guanosine monophosphate
(cGMP), a nucleotide that is involved in several vital intracellular
signalling cascades and physiological processes [1]. Although NO
is the preferred ligand for sGC, activating the enzyme several
hundred fold over its basal level, other gaseous and synthetic
activators, such as carbon monoxide (CO) and the benzylindazole
derivative 3-(59-hydroxymethyl-29-furyl)-1-benzylindazole (YC-1)
respectively, have been identified. While only a moderate
activator, CO would seem to mediate its action via the same
mechanism as NO. YC-1 on the other hand employs a totally
different strategy, binding to an allosteric site on the enzyme
thereby increasing the maximal catalytic rate. Such an action
produces a 10-fold increase in basal sGC activity independently of
other ligands, while also potentiating the responses to subsequent
exposure to such agents [2]. Given the above it is evident that
there are more ways than one to activate sGC. Importantly the
physiological relevance of actions that modulate the response of
sGC to other ligands remains in question.
Perhaps one of the most significant roles for the NO/sGC axis is
in the control of vascular tone [3–5], a function that is essential to
maintaining blood flow and oxygen/nutrient delivery to tissues. As
such, in response to NO produced by adjacent endothelial cells,
sGC located within vascular smooth muscle is activated and the
subsequent production of cGMP mediates vasorelaxation. Since
CO can also induce this cGMP-dependent response, it is perhaps a
little surprising, given that NO, CO, and molecular oxygen (O2)
differ by only one valence electron, that a role for O2 in this
process has not been identified.
Conventional understanding would suggest that O2 simply does
not bind to sGC [6–8], at least not in the same way as NO and
CO. However changes in O2 tension are widely recognised to
influence vascular tone. For instance, via the regulation of specific
potassium channel activity, O2 plays a major role in the control of
pulmonary vascular tone [9,10]. Perhaps of more relevance to an
interaction with sGC is our previous demonstration that the
relaxation response to endogenous NO stimulation or exogenous
NO addition is enhanced the lower the O2 tension [11], implying
an inverse relation between NO effectiveness and O2. These
factors contribute to the concept of ‘‘hypoxic vasodilation’’, an
innate physiological response designed to maintain tissue perfusion
in the face of falling O2 concentrations [12–16]. While the exact
mechanisms that underlie this response have been the subject of
active research and debate for many years, it is now widely
accepted that activation of sGC is intrinsically involved.
The introduction of oxygenated red blood cells (RBCs) to
hypoxic tissues is now well recognised to immediately induce
vasorelaxation. However, while these cells would certainly, and
very quickly, release O2 under such conditions, the latter has been
overlooked as a potential mediator of the relaxation response in
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favour of more conventional activators of s’GC. To this end,
oxygenated haemoglobin-derived nitrosothiol (HbSNO) [17],
nitrite (NO2
2)-derived NO as a consequence of deoxyhaemoglo-
bin nitrite reductase activity [15,20], and RBC-derived adenosine
triphosphate (ATP) stimulation of endothelium-dependent release
of NO and prostacyclin [21,22] have all been postulated to
mediate ‘‘hypoxic vasodilation’’.
While all or any of the above could contribute to RBC-induced
vasodilation in the acute setting, it would seem that none provides
a totally clear mechanism. The data described in this manuscript
advocates an alternative and more straight-forward candidate,
molecular O2. Therefore, the aim of the present study was to
investigate whether O2 could act as a possible direct ligand for
sGC and/or a modulator of the actions of other preferred ligands.
To accomplish these aims two model systems were used; an
isolated sGC enzyme system and an isolated blood vessel system,
both of which allowed for tight control of the local O2
environment. Importantly, these models not only allowed us to
probe O2-dependent mechanisms but also to investigate how these
align with the known features of the putative sGC-dependent
relaxants described above.
Materials and Methods
Ethics Statement
Animal. In accordance with the United Kingdom Animal
(Scientific Procedures) Act of 1986, this study did not require a
Home Office project license because no regulated procedures were
carried out. White, male New Zealand rabbits were humanely
killed at a designated establishment by sodium pentobarbitone,
which is an appropriate method under Schedule 1 of the Act.
Human. Methods requiring human blood samples were fully
approved by the local research ethics committee (South East Wales
Research Ethics Committee) and the joint NHS/University
Research and Development Office (Cardiff and Vale University
Health Board). All healthy volunteers gave written informed
consent.
Materials
L-NG-monomethyl Arginine (L-NMMA) and 1H-[1,2,4] ox-
adiazolo-[4, 3-a] quinoxalin-1-one (ODQ) were from Alexis
Biochemicals. Soluble guanylate cyclase (sGC) purified enzyme
was from Axxora as $90% pure a1b1. Methylamine hexamethy-
lene methylamine (MAHMA) NONOate (NOC-9) was from Enzo
Life Sciences. 2, 3-diphosphoglycerate (2, 3-DPG), YC-1, PEG-
SOD (polyethylene glycol superoxide dismutase) and PEG-CAT
(catalase) were from Sigma Aldrich.
Isolated sGC Study
All experiments were performed in an Invivo2 Hypoxia
Workstation 400 (Ruskin). Normoxic experiments were carried
out at 37uC and 20% O2/5% CO2 via a 25% O2/5% CO2 gas
cylinder (BOC). Hypoxic experiments were maintained at 37uC
and ,0% O2/5% CO2. Reagents were allowed to equilibrate for
1 hour before all tests were completed. Precise buffer O2
concentrations for these experiments are also shown in Table 1.
The pure sGC enzyme was reconstituted in buffer (Tris
50 mmol/L, DTT 1 mmol/L, 0.5% BSA, pH 7.4) and diluted 1
in 200 in assay buffer (Tris 50 mmol/L, EGTA 100 mmol/L,
MgCl2 0.3 mmol/L, 0.045% BSA, pH 7.4. GTP, dissolved in
equimolar MgCl2, was then added to a final concentration of
1 mmol/L to start the reaction. As appropriate, NOC-9 (to give
final concentrations of 0.118, 1.118, 11.8 and 118 mmol/L) or YC-
1 (100 mmol/L) were added at the same time as the GTP. In
experiments utilising superoxide dismutase (SOD) and catalase
(CAT), agents were added 60 minutes prior to GTP. Hyperoxic
samples were prepared by perfusing the buffer-enzyme mix with
95% O2/5% CO2. All reactions were incubated for 10 minutes at
37uC, after which boiling inactivation buffer (Tris 50 mmol/L,
EDTA 4 mmol/L, pH 7.5) was added in 4 times excess. Samples
were then heated to boiling point before storage at 220uC for
further analysis.
cGMP ELISA
Sample cGMP content was measured by commercial ELISA
(R&D Systems) as directed in the kit manual.
Isolated Vessel Preparation
Male New Zealand White rabbits (2–2.5 kg) were killed by a
lethal dose of sodium pentobarbitone (120 mg/kg, i.v) under
Schedule 1 guidelines (see ‘Ethics statement’). Subsequently the
thoracic aorta was carefully removed and placed in fresh Krebs
buffer (composition (mmol/L): NaCl 109.2, KCl 2.7, KH2PO4
1.2, MgSO4 1.2, NaHCO3 25, Glucose 11, CaCl2 1.5) on ice.
Excess adipose tissue was removed from the aorta and 8 rings,
2 mm in width, were prepared.
For isometric tension recording, rings were suspended in tissue
baths containing 5 ml of Krebs at 37uC and gassed with 95% O2/
5% CO2. Resting tension was set to 2 g. Signals from the
transducer (AD Instruments, Chalgrove, UK) were amplified and
visualised on the Powerlab/Chart 4 for Windows software. All
rings were allowed to equilibrate for 60 minutes prior to
experimentation.
Constriction-relaxation exercises to 1 mmol/L phenylephrine
(PE) and 10 mmol/L acetylcholine (ACh) (Sigma Aldrich),
respectively, were performed in order to establish both smooth
muscle and endothelial integrity.
In order to equilibrate the rings in defined levels of hypoxia,
the gas supply was switched to the appropriate O2 content
(ensuring balance of N2 and 5% CO2) for 10 minutes.
Constriction to PE was tested across a broad range of
concentrations and the appropriate PE concentration to achieve
80% of maximal attainable constriction used in all studies. For
hypoxic studies (0% O2), rings were typically exposed to
3 mmol/L PE in order to achieve a similar sub-maximal
constriction as observed in normoxic rings. The O2 concentra-
tion measured in the tissue bath equilibrated under hypoxic
conditions was 0.9% (equivalent to 9 mmol/L O2) as we have
detailed previously [11].
Krebs Samples
Krebs solution was gassed at 95% O2/5% CO2 in order to
achieve 95% O2 samples. 21% O2 samples were allowed to
equilibrate with the atmosphere. 0% O2 samples were gassed
with 95% N2/5% CO2. In order to accurately measure O2
concentration within these equilibrated Krebs buffer samples,
electron paramagnetic resonance (EPR) oximetry was undertak-
en utilising N15 per-deuterated tempone (2,2,6,6-tetra-methyl-4-
piperidone; PDT) as the O2-sensitive probe. In brief, the
spectral line width obtained from PDT (,5 mmol/L) shows a
linear relationship with O2 concentration and sample readings
can be measured against known standards. This technique
measures O2 with an accuracy of 60.2% O2 in our hands as
we have described in detail previously [23]. The precise O2
concentrations within ‘‘95%’’, ‘‘21%’’ and ‘‘0%’’ buffer are
shown in Table 1.
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Haemoglobin (Hb) Samples
Venous RBCs were lysed and diluted 1 in 3 in PBS (0.9%
sodium chloride w/v), of which 250 ml was then loaded on to a
Sephadex G25 M column (GE Healthcare). Samples of pure Hb
were collected in fractions for use in the myograph studies. The
HbO2 content was verified by blood gas analysis as described (see
‘Venous RBC samples’). The volume used in the myograph studies
gave a final O2 concentration in the tissue bath of 30.9 mmol/L
which was equal to the O2 content of the tissue bath following
addition of either buffer or RBC samples.
Venous RBC Samples
Blood was drawn from the antecubital vein of healthy
volunteers and immediately centrifuged at 12006g for 5
minutes. The plasma layer and buffy coat were removed and
replaced with an equivalent volume of gassed (95% O2/5%
CO2) phosphate buffered saline (PBS). Following re-centrifuga-
tion at 12006g for 5 minutes the PBS layer was removed. In
order to achieve RBCs of varying O2 saturation, the cells were
firstly diluted ,1:3 with PBS and loaded on to a thin film
rotating tonometer, which was purged with O2/CO2 to achieve
higher saturations or N2/CO2 for lower saturations as we have
described previously [24]. The O2 saturation of representative
RBC samples was measured on an OSM3 Hemoximeter
(Radiometer, Copenhagen).
In vitro NO Analysis
Phosphate buffered saline (PBS), pH 7.4, was kept at 37uC in a
reaction vessel purged with a flow of nitrogen gas feeding into a
Nitric Oxide Analyser (NOA) 280i (Analytix) for on-line ozone-
based chemiluminescence (OBC) detection of NO. NOC-9 was
reconstituted in 0.1M sodium hydroxide (NaOH) to give a final
stock concentration of 24 mmol/L and kept on ice in the dark. For
the experimental samples, the NOC-9 was further diluted in 1 ml
of PBS (protected from light in a sealed vessel) to give the following
concentrations (in mmol/L): 2.4; 1.2; 0.24; 0.12 and 0.024. In
order to compare NO release under different conditions, the PBS
was either pre-equilibrated to 0% or 95% O2 by vigorous
bubbling. Samples were incubated for 10 minutes at 37uC, after
which 200 ml of the gas layer was drawn up using a Hamilton
syringe and injected immediately into the purge vessel for OBC
analysis. After the signal trace returned to baseline values, 200 ml
of the corresponding PBS sample was drawn up and injected into
the purge vessel. Data were recorded in real time and presented as
area under the curve (Liquid software).
Statistical Analysis
All data were analysed by one-way ANOVA plus Tukey’s or
Dunnett’s post hoc test or Student’s t test as appropriate. Pearson’s
correlations were assessed and coefficients are shown where
appropriate. All data are expressed as mean 6 standard error
(SEM). Differences were considered significant where p,0.05.
Results
Isolated Pure sGC Activity in Normoxia/Hypoxia
A striking observation of these experiments was the difference in
basal sGC activity in normoxia (,100 pmol/ml) compared to
hypoxia (,30–40 pmol/ml) (Figure 1a).
Exposure to the NO donor, NOC-9, at various concentrations
(0, 0.118, 1.118, 11.8 and 118 mmol/L), stimulated cGMP
production in normoxia in a concentration dependent manner
(108.4610.78 pmol/ml to 513.7630.12 pmol/ml) (Figure 1b). In
hypoxia, cGMP production was similar across all concentrations of
NOC9 compared with the control (,500 pmol/ml vs.,30 pmol/
ml) (Figure 1c).
In separate experiments, YC-1 (100 mmol/L), a compound
known to stimulate sGC without direct interaction with the sGC
haem group [2], was added to sGC under hypoxic and
normoxic conditions as above. While the addition of YC-1
enhanced the amount of cGMP produced by the enzyme,
importantly the increase from baseline was similar in both
normoxia and hypoxia (,46.20 pmol/ml & ,44.86 pmol/ml,
respectively) (Figure 1d).
To deduce whether superoxide (O2
2) was having a direct
influence on sGC activity in normoxia, SOD and CAT were
incubated with the enzyme to observe any change in cGMP
levels produced. Compared to control levels, SOD and CAT
did not significantly affect the activity of the isolated enzyme
(Figure 1e).
Effects of Buffer Containing Increasing O2 on Vascular
Tone in Hypoxia
Tetrameric Hb has the ability to carry four O2 molecules [25].
The O2 content of a RBC suspension is therefore much greater
than buffer equilibrated with the same O2 concentration. In order
to attain a comparable O2 delivery, Krebs buffer was gassed with
95% O2/5% CO2, either in a sealed glass bottle (high O2
saturation) or an open container allowed to equilibrate with
atmospheric air (21% O2), or with 95% N2/5% CO2 (0% O2).
200 ml of the appropriate Krebs buffer samples were then added to
tissue baths containing hypoxic PE-pre-constricted aortic rings as
described above. A 3 fold greater (p,0.01) relaxation was
Table 1. Example O2 contents of replica buffer samples for both the myograph and hypoxic chamber, read from a PDT-probe
standard curve (EPR oximetry).
Sample
Stock Buffer O2 concentration
(mmol/L)
Final Tissue Bath concentration
(mmol/L)1
0% 49 1.96
21% 175 7.0
95% 772 30.9
Hypoxic chamber 0% +1 hour 38
Hypoxic chamber 20% +1 hour 197
1represents the effective O2 concentration added to each tissue bath. The existing O2 in the ‘‘hypoxic’’ bath perfused with N2/CO2 was 0.9% (equivalent to 9 mmol/L O2).
doi:10.1371/journal.pone.0057162.t001
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observed following addition of highly oxygenated versus minimally
oxygenated samples (Figure 2).
Effects of Administering a Constant O2 Supply to Hypoxic
Tissue
In separate experiments, aortic tissue was incubated in hypoxia
and pre-constricted with PE as described above. The gas supply
was then switched to 95% O2/5% CO2 permanently. An
instantaneous and transient relaxation response, akin to that
Figure 1. Measurement of cGMP as an index of sGC activity in normoxic and hypoxic conditions. a. Comparing cGMP production in
hypoxia (0% O2), normoxia (,21% O2) and hyperoxia (95% O2). Normoxia and hyperoxia stimulated an increased production of cGMP compared with
hypoxia. (***p,0.001 cf. hypoxia, n = 4–6). b. Concentration response curve to NOC9 under normoxic conditions. Significant differences were
observed at each concentration level compared to the control containing no NOC9, ***p,0.001 cf. 0 mmol/L, **p,0.01 cf. 0 mmol/L and *p,0.05 cf.
0 mmol/L (n = 3 to 6 experiments). c. Concentration response curve to NOC9 under hypoxic conditions. Significant differences were observed at each
concentration level compared to the control containing no NOC9, ***p,0.001 cf. 0 mmol/L (n = 3 to 6 experiments). cGMP detected for 0.118 and
1.118 mmol/L NOC9 were much greater than the levels in normoxia initiated by the same concentrations. d. Exposure of sGC to the NO-independent
activator YC-1 (100 mmol/L). Paired analysis of cGMP levels catalysed by sGC revealed a significant increase in the normoxic control versus hypoxic
control, ***p,0.001 cf. hypoxia control. The addition of YC-1 in normoxia induced an increase in cGMP compared to control but this was not
significant. A similar trend was observed in hypoxia, however the addition of YC-1 induced a significant rise in cGMP, *p,0.05 cf. control. (n = 4). e.
SOD (100 U/ml) and CAT (250 U/ml) incubated with sGC in normoxia stimulated a similar level of cGMP compared to the control, p.0.05 cf. control.
(n = 4).
doi:10.1371/journal.pone.0057162.g001
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following addition of O2 buffer solution, was observed (data not
shown).
Effects of sGC Inhibition on O2-mediated Vasorelaxation
To confirm that O2-mediated relaxation of hypoxic vessels is
mediated via the sGC pathway, the sGC inhibitor, 1H-[1,2,4]
oxadiazolo-[4, 3-a] quinoxalin-1-one (ODQ) which binds to the
haem moiety of sGC, was introduced 30 minutes prior to PE
constriction. The presence of ODQ caused a significant inhibition
of the relaxation induced by a bolus of 95% O2/5% CO2-gassed
Krebs buffer (0.7260.28% vs. 17.8161.90% in the absence of
ODQ, n= 7, ***p = 0.001) (Figure 3).
Influence of Endothelial NO Synthase (eNOS) on O2-
mediated Vasorelaxation
Experiments were repeated in the presence of the eNOS
inhibitor L-NG-monomethyl arginine (LNMMA, 300 mmol/L for
30 minutes). Figure 4 demonstrates that this agent has no effect on
the oxygenated buffer-induced relaxations (n = 4, **p,0.01 cf. 0%
O2).
Vascular Effects of Superoxide and Hydrogen Peroxide
It is well acknowledged that reperfusion of O2 to hypoxic vessels
causes the generation of O2 radical species [26]. Therefore, it was
necessary to ascertain whether O2
2 had a role in the myography
experiments conducted here. SOD and CAT linked to polyeth-
ylene glycol (PEG) were therefore used to abrogate any effects of
intracellular O2
2 and hydrogen peroxide (H2O2) generation,
respectively. Neither PEG-SOD, PEG-CAT, nor both together
had a significant effect on the O2-induced relaxation of vessels in
hypoxic conditions (Figure 5).
Effects of Oxygenated RBCs on Vascular Tone in Hypoxia
RBCs equilibrated at a higher O2 saturation (98.2260.45% O2,
n = 13) caused significantly (p,0.001) more relaxation than those
of partial saturation (51.4366.16% O2, n= 4) or low saturation
(20.4065.28% O2, n= 13) when administered to a hypoxic tissue
bath (Figure 6). These data confirm a positive relationship between
RBC O2 saturation and the relaxation induced in hypoxic aortic
tissue (Pearson’s correlation coefficient r = 0.815, p,0.0001).
Effects of RBC O2 Cycling upon Hypoxic Vasorelaxation
Highly oxygenated RBC (98.2260.45% O2, n = 13) were
administered to hypoxic aortic rings to induce relaxation. In a
parallel sample, highly oxygenated RBC were first deoxygenated
to ,20% O2 (20.6861.66% O2) before reoxygenation
(97.7060.39% O2, n= 4) and subsequent addition to hypoxic
rings. There was no significant difference in the relaxation induced
post deoxy-oxy cycling of RBCs compared with controls
(8.2862.97% vs. 12.0063.60%).
The RBC O2 cycling prompted further investigation into the
movement of the relaxing moiety in and out of the cell. RBC were
deoxygenated to a low saturation (22.3861.69% O2) before re-
suspension in fresh oxygenated buffer to give a saturation of
,98% (98.0560.65% O2, n = 4). As above, there was no
significant difference between the relaxations induced by buffer-
Figure 2. Krebs buffer samples introduced to hypoxic aortic
rings. Maximum relaxation was demonstrated with 95% oxygenated
buffer samples compared with 0% O2 samples (all n = 6, **p,0.01 cf.
0%).
doi:10.1371/journal.pone.0057162.g002
Figure 3. The effect of sGC inhibitor, ODQ, upon O2-mediated
relaxation. In the presence of ODQ (10 mmol/L) the relaxation
response to 95% oxygenated buffer was almost completely inhibited
(both n= 7, ***p,0.001 cf. control).
doi:10.1371/journal.pone.0057162.g003
Figure 4. The influence of eNOS inhibitor, LNMMA, upon O2-
mediated relaxation. LNMMA had no effect on the relaxation
responses. Similarly to Figure 3, 95% oxygenated buffer samples
generated the greatest relaxation compared with 0% O2 samples (all
n = 4, **p,0.01 cf. 0% O2).
doi:10.1371/journal.pone.0057162.g004
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replaced RBCs compared with controls (12.9761.89% vs.
12.0063.60%).
Influence of 2, 3-diphoshoglycerate on RBC-mediated
Hypoxic Vasorelaxation
2, 3-diphosphoglycerate (2, 3-DPG), (5 mmol/L) discourages
O2 from binding to Hb, facilitating diffusion into respiring tissue
[27]. In the presence of 2, 3-DPG, hypoxic PE-pre-constricted
aortic rings relaxed significantly more (10.7561.11% vs.
8.2561.36%, n= 4, *p,0.05) to addition of oxygenated RBCs
than in its absence, supporting the role of this intermediate in the
regulation of O2 delivery.
Comparison of O2-mediated Vasorelaxation by RBCs,
Buffer or Isolated Hb
In additional experiments, purified oxygenated Hb was
prepared from RBCs and applied to tissue baths containing
hypoxic PE-pre-constricted aortic rings as described above.
Samples of RBC, buffer or Hb were prepared such that addition
to the tissue bath resulted in final O2 concentrations of,30 mmol/
L. Figure 7 shows grouped results confirming very similar
relaxation responses for RBCs, Hb and oxygenated buffer (n = 4,
p.0.05).
Effects of Oxygenated RBCs on Vascular Tone at Different
Tissue pO2
In separate experiments, aortic tissue was perfused for 10
minutes with 1%, 2%, 5%, 21% or 95% O2/5%CO2. Constric-
tion to PE was normalised to 80% of maximum at each O2
tension, then fully oxygenated RBCs were administered. This is in
contrast to most of the experiment described above in which
varying O2 was introduced to hypoxic tissue or isolated sGC.
Figure 5. Effect of O2
2 and H2O2 on vessel relaxation in hypoxia. The inhibition of O2
2 radicals (100 U/ml PEG-SOD) and H2O2 (250 U/ml
PEG-CAT) within the vessel system did not affect the magnitude of the relaxation to a bolus of 95% oxygenated buffer. PEG-SOD (100 U/ml) plus ODQ
(10 mmol/L) abolished most of the relaxation (*p,0.05 cf. control). All n = 3.
doi:10.1371/journal.pone.0057162.g005
Figure 6. Varying O2 saturations of RBC administered to
hypoxic rabbit aortic rings. Partially saturated RBC (,50%) and
low saturated RBC displayed a significantly lower relaxation than RBC of
high saturation, **p,0.01 and ***p,0.001 respectively. (High satura-
tion, n = 13; partial saturation, n = 4; low saturation, n = 13).
doi:10.1371/journal.pone.0057162.g006
Figure 7. Effects of various oxygenated samples on relaxation
responses of hypoxic vascular tissue. Krebs buffer, Hb and RBC
samples of equal O2 content (,30 mmol/L) administered to hypoxic
rabbit aortic rings. There was no difference in the magnitude of the
relaxations produced (p.0.05) (n = 4).
doi:10.1371/journal.pone.0057162.g007
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Significantly greater relaxation was induced at tissue incubated in
1% (***p,0.001 cf. 95% O2) and 2% O2 (*p,0.05 cf. 95% O2)
(n = 6) (Figure 8).
Effects of O2 on the Liberation of NO from NOC9
In order to test whether production of NO from NOC-9 was
affected under normoxic or hypoxic conditions, we measured NO
released from NOC-9 into both the gaseous and liquid phases of a
PBS sample across a range of NOC-9 concentrations. Our data
confirms that the quantity of NO detected in both the gas and
liquid phases (quantified as area under the curve), are not
significantly different under normoxic versus hypoxic conditions
(n = 3, p,0.05) (Figure 9).
Discussion
The aim of the present study was to investigate the effects of O2
on sGC function, and in particular, on responses of the enzyme to
known ligands and stimulators/activators. Our data conclusively
shows that molecular O2 has the ability to increase sGC activity in
the absence of NO. Moreover, exposure of sGC to hypoxic
conditions revealed a novel modulatory effect of O2 on NO-
stimulated sGC activity. Our isolated vessel model confirms that
the sGC-mediated transient relaxation of tissues in hypoxic
conditions can occur simply by injecting a bolus of oxygenated
buffer. As such, the data presents an important and hitherto
undescribed role for O2 in the production of cGMP.
As previously described, and when compared to NO, sGC can
be activated to a lesser extent by other diatomic species such as
CO [28]. However, despite the obvious structural similarity, the
ability of O2 to interact with sGC, and specifically with the haem
moiety to form a stable complex, has been overlooked [6–8,29,30].
Importantly, the data described herein goes against conventional
thinking and supports a role for O2 in upregulating baseline sGC
activity as evidenced by greater cGMP production in our isolated
enzyme system under normoxic compared to hypoxic conditions.
Moreover, the presence of O2 is also shown to have a modulatory
effect on the subsequent activation of sGC by NO. Thus following
addition of NO to hypoxic sGC, similar large increases in cGMP
were observed irrespective of NO concentration. Conversely, a
concentration dependent response to NO was revealed for
normoxic sGC, the largest response to 23.6 mmol/L NO being
similar to that produced by 100-fold less NO under hypoxic
conditions. As such, the removal of O2 from sGC both decreases
baseline enzyme activity and makes it more sensitive to activation
by lower concentrations of the NO. That the NO and haem-
independent sGC activator, YC-1, produced a different response,
similar increases in cGMP above baseline being observed in both
normoxia and hypoxia, would support a possible role for the
interaction of O2 with the sGC in a way that modulates the haem
group. sGC has been reported to function optimally at intracel-
lular O2 concentrations between 20 and 40 mmol/L [31]
indicating the ability of sGC to distinguish between ligands.
Importantly, we confirmed that the amount of NO released by the
NO donor NOC-9 was similar under both hypoxic/normoxic
experimental conditions and thus cannot be accountable for the
results achieved. While a stable isolatable complex of O2 and sGC
has not been identified, it is possible that intracellular concentra-
tions of O2 could have an influence on enzyme activity. The
majority of studies conducted with sGC are under anaerobic
conditions [8,32,33] however Ullrich and colleagues [34] observed
a decrease in cGMP produced by platelet sGC following N2
Figure 8. Relaxations observed after addition of RBC samples
to aortic rings equilibrated at various O2 saturations. Tissues
held at a lower O2 (1 and 2%) relaxed significantly more to oxygenated
RBC’s, ***p,0.001 cf. 95% and *p,0.05 cf. 95%, respectively.
doi:10.1371/journal.pone.0057162.g008
Figure 9. NO liberation from NOC-9 under normoxic versus hypoxic conditions. Gas and liquid samples drawn up from reaction vessels
incubated with varying concentrations of NOC-9, were injected into the NOA. The solutions were either equilibrated at 0 or 95% O2/5% CO2 prior to
the addition of NOC-9. There was no difference in the total NO detected in either gas or liquid samples under (n = 3, p,0.05).
doi:10.1371/journal.pone.0057162.g009
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addition compared to basal conditions. In addition, Soret band
analysis by UV spectrophotometry show subtle changes in sGC
binding under oxygenated conditions [35].
In order to substantiate our isolated enzyme data, we next
developed an in vitro vascular model. Isolated rabbit aortic rings
pre-constricted with PE under hypoxic conditions were exposed to
single bolus additions of buffer equilibrated with varying O2
concentrations. In such experiments, transient and concentration-
dependent relaxation responses to O2 were produced. The
involvement of sGC and classic cGMP-dependent downstream
signalling in smooth muscle to induce relaxation was confirmed by
the fact that the O2-dependent responses were inhibited in the
presence of ODQ, the irreversible haem-site inhibitor of sGC
[36,37]. Since eNOS function is close to normal even under
hypoxic conditions in this vascular preparation [38] a role for
endothelium-dependent NO in the responses described above was
also investigated. In that the relaxation induced by O2 was
insensitive to eNOS inhibition by LNMMA, such an involvement
was ruled out. Together these observations support the role of O2
in sGC activation already described above.
The in vitro isolated vascular system used in the present study
relates closely to ischaemia reperfusion, where a vessel of low
oxygenation quickly becomes reperfused with O2, for example
following removal of an occlusion [39]. Under such circumstances
many studies have shown evidence for the generation of free
radical species [26,40–43]. Taken with the recently observed
inhibitory effect of O2
2 on sGC [44] it was important to confirm
that O2
2/H2O2 were not involved in the sGC-driven effects we
observe following addition of O2 to the tissues. To this end
experiments were repeated in the presence of the appropriate cell
permeable inhibitors (PEG-SOD and PEG-CAT). That the
relaxation responses to O2 were again insensitive to these agents
ruled out this possibility.
In order to further translate our study, we repeated our in vitro
studies, substituting the O2 buffer bolus for highly O2-saturated
human RBCs. When oxygenated, RBCs have the ability to change
Hb conformation into the R state. Indeed, in this state Hb has the
capacity to offload O2 and in vivo this is conveyed by the transfer of
O2 from the blood to respiring tissue beds. Importantly, such a
mechanism is crucial for RBCs to give up O2 when encountering a
hypoxic environment. Therefore, by altering the saturation of
RBCs, we could change the proportions of R and T state Hb and
therefore potentially show the preference for the RBCs to give up
O2 in the R state. The highly saturated (98.2260.45% O2) RBCs
induced a significantly greater relaxation of hypoxic rabbit aortic
rings compared with RBCs of low saturation (20.4065.28% O2)/
mainly T state Hb. Consequently, purified Hb was used in further
experiments to confirm the relaxant species was released directly
from Hb without the need for RBCs per se. Interestingly, RBCs,
Hb and buffer boluses of comparable O2 content induced very
similar relaxations of the hypoxic vessel tested in the present study.
Additional experimentation demonstrated that the relaxant species
is not depleted by repeat deoxygenation/re-oxygenation cycles,
confirming the species is readily replenishable and is essentially
delivered by simply replacing the Krebs buffer surrounding the
hypoxic RBCs with adequately oxygenated buffer.
For some time it has been suggested that RBC-induced
vasorelaxation is linked to Hb allostery, although a particular
interest has focussed on the now well established vasodilatory
capacity of HbSNO. We ourselves followed this line of investiga-
tion demonstrating greater RBC-induced relaxations with increas-
ing HbSNO [45], and an altered HbSNO to relaxation response
in highly glycosylated RBCs that we linked to an effect on the Hb
O2 saturation curve [11]. Concurrently, we also measured the
transient release of O2 into the tissue bath but at the time took this
to be a consequence of Hb transition rather than the relaxant
species. Subsequent studies have later confirmed the potential for
O2 in buffer alone to induce relaxation, but considered this control
considerably less than the relaxation induced by RBCs [15].
Importantly, the samples and the buffer controls were perfused
with the same gas, but crucially were not equalised in terms of O2
content in the latter study.
Further studies have confirmed the importance of Hb allostery
in RBC-mediated hypoxic vasorelaxation [20,46] although they
contend partially oxygenated Hb acts as a NO2
2 reductase that
converts readily available NO2
2 to free NO to exhibit vasodila-
tation. Whilst both HbSNO and NO2
2 exhibit properties that
suggest they could contribute to RBC-induced relaxation [15,18–
20,45], neither completely satisfies the characteristics of a readily
replenishable, freely diffusing relaxant species that is present in
simply oxygenated buffer as we show here.
A potential criticism of our model system is that we induce an
artificial condition in tissue whereby a defined unit of O2 (either
buffer or RBCs) is introduced to an essentially hypoxic environ-
ment. To address this, we conducted studies under conditions
where either fully oxygenated RBCs or buffer samples were
administered to baths containing tissue equilibrated at various O2
concentrations. Of physiological significance, O2-mediated relax-
ation was inversely related to the extent of tissue oxygenation, in
complete concurrence with established HbO2 delivery and
matching the need for dilation across the whole O2 range.
Furthermore, we conducted studies in which O2 was confirmed as
a relaxant of blood vessel segments since the first response to
administration of a constant supply of O2 being re-introduced into
a hypoxic setting was transient relaxation.
In previous work we had demonstrated how vessel relaxation
response to exogenous addition of NO is enhanced with lower O2
tension [11]. This had been ascribed to the influence of O2 on
competing mechanisms, including direct effects on constriction.
However, taken together with the data we show herein, would
indicate a more direct interplay between the effects of NO and O2
on sGC. Clearly, NO is the preferred ligand as shown by its ability
to fully activate isolated sGC in our model system at a
concentration as low as 10 mmol/L even in the presence of
210 mmol/L O2 (‘‘normoxia’’). Under conditions where NO is
relatively low, O2 may influence sGC in two ways; the influence of
weak sGC activation by O2 may accrue greater importance, and
the effect of NO will be enhanced.
In conclusion, our data has revealed the novel finding that in the
presence of O2, sGC can stimulate an increased production of
cGMP from GTP compared to under hypoxic conditions. The use
of YC-1 in our isolated enzyme model clearly enhanced cGMP
production however the compound was not affected by the
presence of O2, perhaps suggesting the effects of O2 on the enzyme
may be occurring at a site independent to that of YC-1.
Furthermore, we show that O2 can modulate the effect of NO
(concentration-dependent) upon the enzyme, indicative of an
interaction of O2 with the haem of sGC or an indirect involvement
with haem via an allosteric site. Armed with the knowledge that
,6% of sGC within vascular tissue is stimulated by NO under
normal conditions [47], our findings may have important
consequences in the wider context of vascular relaxation via
stimulation of sGC across the physiological and pathological O2
range.
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